Sino BiologicalInc Dividends and Buybacks
Dividend criteria checks 2/6
Sino BiologicalInc is a dividend paying company with a current yield of 3.05%.
Key information
3.0%
Dividend yield
2.0%
Buyback Yield
| Total Shareholder Yield | 5.0% |
| Future Dividend Yield | 3.0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥2.000 |
| Payout ratio | 166% |
Recent dividend and buyback updates
Recent updates
Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 04
Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up
Sep 30Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00
May 21Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce
May 08Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders
May 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 301047 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 301047 has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
| Sino BiologicalInc Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (301047) | 3.0% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Biotechs) | 1.2% |
| Analyst forecast (301047) (up to 3 years) | 3.0% |
Notable Dividend: 301047's dividend (3.05%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 301047's dividend (3.05%) is in the top 25% of dividend payers in the CN market (2.08%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (165.9%), 301047's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (147.5%), 301047's dividend payments are not well covered by cash flows.